FTC Challenges Lundbeck Drug Monopoly In 8th Circ.

Law360, New York (January 3, 2011, 5:01 PM EST) -- The Federal Trade Commission has fired the opening salvo in its appeal of an antitrust suit against Lundbeck Inc., arguing a lower court improperly cleared the drugmaker of violations related to its acquisition of the only two drugs to treat a life-threatening heart condition.

The FTC filed its opening brief on Dec. 27 in the U.S. Court of Appeals for the Eighth Circuit, arguing Judge Joan N. Ericksen of the U.S. District Court for the District of Minnesota improperly threw out the case when she decided...
To view the full article, register now.